Safety and Efficacy of Pentavalent (G1, G2, G3, G4 , and P1) Human-Bovine Reassortant Rotavirus Vaccine in Healthy Infants
Latest Information Update: 06 May 2022
At a glance
- Drugs Rotavirus W179-9 vaccine (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Acronyms FES; REST
- Sponsors Merck & Co; Merck Sharp & Dohme
- 18 Apr 2019 Results of survey conducted through questionnaire (n=5764) assessed vaccination effect against the onset of celiac disease in childhood and adolescence published in the Pediatric Infectious Disease Journal.
- 26 Oct 2008 Results of a post-hoc analysis reported at the ICAAC, according to a Merck media release.
- 29 Oct 2005 New trial record.